Effects of Subcutaneous Actemura and MTX Blending in RA

Trial Profile

Effects of Subcutaneous Actemura and MTX Blending in RA

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 04 Aug 2015

At a glance

  • Drugs Tocilizumab (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms eSCRAMBLE
  • Most Recent Events

    • 03 Aug 2015 Status changed from not yet recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
    • 29 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top